# CHEMOMAB THERAPEUTICS LTD SPONSORED ADS

CHEMOMAB THERAPEUTICS LTD SPONSORED ADS is a security (CUSIP 16385C203) tracked across SEC portfolio filings. 14 institutional managers reported $528K on Form 13F as of 2026-06-30.

## Summary

- Issuer: CHEMOMAB THERAPEUTICS LTD
- Class: SPONSORED ADS
- CUSIP: 16385C203
- 13F holders: 14
- 13F value: $528K
- 13F period: 2026-06-30
- N-PORT fund positions: 0

## Top institutional holders (Form 13F)

| Manager | Location | Value | Shares |
| --- | --- | --- | --- |
| [ADAR1 Capital Management, LLC](https://search.stillhousedata.com/firm/299694) | AUSTIN, TX | $126K | 80,000 |
| [CITADEL ADVISORS LLC](https://search.stillhousedata.com/firm/148826) | MIAMI, FL | $101K | 64,182 |
| KESTRA PRIVATE WEALTH SERVICES, LLC | AUSTIN, TX | $100K | 61,710 |
| [Ikarian Capital, LLC](https://search.stillhousedata.com/firm/1778253) | DALLAS, TX | $81K | 51,793 |
| XTX Topco Ltd | LONDON, X0 | $29K | 18,629 |
| [RHUMBLINE ADVISERS](https://search.stillhousedata.com/firm/107151) | BOSTON, MA | $29K | 18,366 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | BALA CYNWYD, PA | $21K | 13,491 |
| BNP PARIBAS ARBITRAGE, SNC | PARIS, I0 | $13K | 8,425 |
| [Philadelphia Investment Partners, LLC](https://search.stillhousedata.com/firm/122733) | Voorhees, NJ | $13K | 8,200 |
| [GAMMA Investing LLC](https://search.stillhousedata.com/firm/312573) | FOSTER CITY, CA | $8K | 4,740 |
| MORGAN STANLEY | NEW YORK, NY | $7K | 4,575 |
| SBI Securities Co., Ltd. | TOKYO, M0 | $55 | 34 |
| UBS Group AG | Zurich, V8 | $13 | 8 |
| Caitong International Asset Management Co., Ltd | HONG KONG, K3 | $13 | 8 |

## More

- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/security/16385C203.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.
